Align Technology, Inc. is a prominent medical device company known for designing, manufacturing, and marketing Invisalign clear aligners and iTero intraoral scanners, along with related services tailored for orthodontists, general practitioner dentists, and professionals involved in restorative and aesthetic dentistry. The company earned an interest income of $16,045,000.00 showcasing its financial investments. Additionally, it incurred an income tax expense of $174,936,000.00 indicating its tax obligations. With an operating income ratio of 0.15 the firm demonstrates its operational profitability margins. The gross profit stands at $2,756,897,000.00 highlighting the company's profitability from core operations, while the weighted average number of diluted shares outstanding is 72,588,000.00 reflecting potential dilution effects. Operating through two main segments—the Clear Aligner segment, which provides a range of treatment options for teenagers and younger patients, and the Scanners and Services segment, which offers advanced scanning solutions—the company serves a wide market that includes the United States, Switzerland, China, and beyond. The stock is priced at $131.39 positioning it in the higher-end market, with an average trading volume of 1,229,281.00 indicating moderate liquidity. Holding a mid-range market capitalization of $11,937,765,333.00 Align Technology, Inc. is recognized as a steady performer in the medical technology field. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape and driving innovation and growth within the Healthcare sector. The diverse product offerings and reliable financial performance underscore Align Technology’s pivotal role in shaping the future of orthodontic and dental treatment solutions.